EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
EIDX
Delisted
EIDX was delisted on the 25th of January, 2021.
102 hedge funds and large institutions have $693M invested in Eidos Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 30 increasing their positions, 27 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
11% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 27
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
102
Holding in Top 10
5
Calls
$16.5M
Puts
$5.7M
Top Buyers
| 1 | +$21.2M | |
| 2 | +$19.4M | |
| 3 | +$12.5M | |
| 4 |
Holocene Advisors
New York
|
+$9.62M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.35M |
Top Sellers
| 1 | -$12.7M | |
| 2 | -$9.44M | |
| 3 | -$5.96M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$5.4M |
| 5 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$5.11M |